fibrinogen and Melanoma
fibrinogen has been researched along with Melanoma in 60 studies
Research
Studies (60)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 30 (50.00) | 18.7374 |
1990's | 9 (15.00) | 18.2507 |
2000's | 9 (15.00) | 29.6817 |
2010's | 8 (13.33) | 24.3611 |
2020's | 4 (6.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Bunch, RT; Hogan, JM; Korman, AJ; Rak, G; Selby, M; Strop, P; Thudium, K; Wang, XT; Zorn, JA | 1 |
Daouti, S; David, JM; Dolfi, S; Garman, B; Jacques, MK; Jiang, C; Koenitzer, JD; Kumar, S; Lako, A; Manjarrez-Orduno, N; Mehta, P; Menard, L; Mukherjee, P; Rai, SC | 1 |
Barberini, F; Boselli, C; Cannavicci, D; Cirocchi, R; Covarelli, P; De Giorgi, V; Rulli, A | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
Fend, F; Goodman, SL; Klein, A; Meyermann, R; Schittenhelm, J; Sipos, B; Tatagiba, MS | 1 |
Hamano, A; Jin, T; Ohno, N; Ohno, S; Okumura, N; Saiki, I; Saitoh, Y; Terada, N | 1 |
de Vries, EG; Hospers, GA; Mäkelburg, AB; Schröder, CP; van den Brom, RR | 1 |
Awsiuk, K; Bernasik, A; Budkowski, A; Lekka, M; Lukes, J; Madej, E; Pabijan, J; Prauzner-Bechcicki, S; Raczkowska, J; Rysz, J; Sepitka, J | 1 |
Chung, CY; Dong, C; Ozdemir, T; Robertson, GP; Zhang, P | 1 |
Brüggemann, LW; Büller, HR; Esmon, CT; Kamphuisen, PW; Richel, DJ; Spek, CA; van Noorden, CJ; van Sluis, GL | 1 |
Edelhauser, G; Gleiss, A; Harmankaya, K; Hoeller, C; Pehamberger, H; Schicher, N; Schindler, K | 1 |
Caracò, C; Crispo, A; Di Monta, G; Marone, U; Mozzillo, N | 1 |
Clanton, J; Donnelly, E; Gao, X; Geng, L; Giorgio, T; Hallahan, D; Qu, S; Scarfone, C | 1 |
BENEDETTO, A; BOSSI, G; ZINA, G | 1 |
Advincula, R; Camerer, E; Cornelissen, I; Coughlin, SR; Duong, DN; Qazi, AA | 1 |
Bhatia, SK; Fu, W; Hammer, DA; Im, JH; Kowalska, MA; Muschel, RJ; Wang, H | 1 |
Caputo, E; Guardiola, J; Lombardi, ML; Luongo, V; Martin, BM; Moharram, R; Pirozzi, G; Tornatore, P | 1 |
Adamson, L; Bartůnková, J; Karlsson, G; Lundqvist, A; Masucci, G; Palmborg, A; Pisa, P; Tobiásová-Czetoová, Z | 1 |
Bale, WF; Dewey, WC; Harper, PV; Marrack, D; McCardle, RJ; Spar, IL | 1 |
Al-Mondhiry, H; Leitzel, K; McGarvey, V | 1 |
Collen, D; Matsuo, O; Rijken, DC | 1 |
Arbeit, JM; Brennan, MF; Jones, DC; Line, BR; Lowry, SF | 1 |
Fujii, K; Imamura, S | 1 |
Chen, YP; Diaz-Gonzalez, F; Ginsberg, MH; Leong, L; Liu, BQ; O'Toole, TE | 1 |
Fujii, K; Lazarus, GS; Schechter, NM | 1 |
Downing, AK; Dwek, RA; Mori, K; Opdenakker, G; Rudd, PM | 1 |
Oshikawa, K; Terada, S | 1 |
Horton, MA; Teti, A; Townsend, PA; Villanova, I | 1 |
Feldman, RI; Howlett, AR; Rosser, MP; Wu, JM | 1 |
Ruoslahti, E; Yi, M | 1 |
Goodman, SL; Haubner, R; Kessler, H; Mang, C; Schwaiger, M; Senekowitsch-Schmidtke, R; Weber, WA; Wester, HJ; Ziegler, SI | 1 |
Honn, KV; Paku, S; Rásó, E; Tímár, J; Tóth, K; Tóvári, J; Trikha, M | 1 |
Felding-Habermann, B; Habermann, R; Pilch, J | 1 |
Fidler, IJ; Gersten, DM; Hart, IR | 1 |
Dintenfass, L; Kammer, S | 2 |
Dintenfass, L | 2 |
Bergut, FA | 1 |
Baba, I; Hayashi, Y; Katagiri, Y; Suzuki, H; Tanoue, K; Yamazaki, H | 1 |
Fischer, BE; Will, H | 1 |
Atkinson, T; Electricwala, A; Emeis, JJ | 1 |
Cheresh, DA; Spiro, RC | 1 |
Cheresh, DA; Cooper, HM; Quaranta, V; Smith, JW | 1 |
Electricwala, A | 1 |
Huang, TF; Knudsen, KA; Niewiarowski, S; Tuszynski, GP | 1 |
Kawachi, S | 1 |
Markland, FS | 1 |
Edgington, TS; Plow, EF | 1 |
Dintenfass, L; Forbes, CD; Milton, GW; Stewart, JH | 1 |
Dintenfass, L; Milton, GW | 1 |
Bettigole, RE; Clifford, GO; Himelstein, ES; Oettgen, HF | 1 |
Galton, DA; Hamilton-Fairley, G; Malpas, JS | 1 |
Damasio, EE; Marmont, AM | 1 |
Hagmar, B | 1 |
Gallmeier, WM; Schmidt, CG; Stier, HW | 1 |
Shulman, NR; Watkins, SP | 1 |
Almersjö, O; Bengmark, S; Hafström, LO; Korsan-Bengtsen, K; Ygge, J | 1 |
Haustein, UF | 1 |
Reviews
4 review(s) available for fibrinogen and Melanoma
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Vemurafenib-Induced Disseminated Intravascular Coagulation in Metastatic Melanoma.
Topics: Acute Disease; Antineoplastic Agents; Biomarkers; Biomarkers, Tumor; Brain Neoplasms; Databases, Factual; Disseminated Intravascular Coagulation; Drug Administration Schedule; Fatal Outcome; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Indoles; L-Lactate Dehydrogenase; Male; Melanoma; Middle Aged; Mutation; Pharmacovigilance; Platelet Count; Proto-Oncogene Proteins B-raf; Recurrence; S100 Calcium Binding Protein beta Subunit; Skin Neoplasms; Sulfonamides; Tumor Burden; Vemurafenib | 2015 |
The biology of cancer invasion and metastasis.
Topics: Animals; Cell Adhesion; Cell Cycle; Cell Division; Cell Membrane; Cell Movement; Cell Survival; Embolism; Fibrinogen; Glucosyltransferases; Humans; Immunity, Cellular; Inflammation; Lymph Nodes; Lymphatic Metastasis; Melanoma; Membrane Lipids; Membrane Proteins; Mice; Microcirculation; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neoplasms, Experimental; Neoplastic Cells, Circulating; Platelet Aggregation; Surface Properties; Thoracic Duct | 1978 |
Re-evaluation of heat precipitation method for plasma fibrinogen estimation: effect of abnormal proteins and plasma viscosity.
Topics: Anticoagulants; Blood Coagulation Tests; Blood Viscosity; Chemical Precipitation; Cryoglobulins; Dextrans; Fibrinogen; Glucose; Hot Temperature; Humans; Kidney Failure, Chronic; Melanoma; Multiple Myeloma; Myeloma Proteins; Serum Albumin | 1976 |
Trials
2 trial(s) available for fibrinogen and Melanoma
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Collagen sealant patch to reduce lymphatic drainage after lymph node dissection.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Collagen; Drainage; Drug Combinations; Female; Fibrin Tissue Adhesive; Fibrinogen; Groin; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Prospective Studies; Seroma; Skin Neoplasms; Thrombin | 2012 |
Other Studies
55 other study(ies) available for fibrinogen and Melanoma
Article | Year |
---|---|
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.
Topics: Animals; Antibodies, Blocking; Antibodies, Monoclonal; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; CTLA-4 Antigen; Fibrinogen; Humans; Immune Checkpoint Inhibitors; Macaca fascicularis; Melanoma; Mice; Nivolumab; Programmed Cell Death 1 Receptor | 2022 |
Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands.
Topics: CTLA-4 Antigen; Fibrinogen; Humans; Immunophenotyping; Leukocytes, Mononuclear; Ligands; Melanoma; Programmed Cell Death 1 Receptor; Tumor Microenvironment | 2023 |
Reduction of postoperative lymphorrhoea in patients undergoing radical lymphadenectomy for stage III melanoma: prospective study using collagen-fibrin patches.
Topics: Axilla; Drug Combinations; Female; Fibrinogen; Humans; Inguinal Canal; Lymph; Lymph Node Excision; Lymphatic Metastasis; Lymphedema; Male; Melanoma; Neoplasm Staging; Postoperative Complications; Prospective Studies; Retrospective Studies; Skin Neoplasms; Thrombin | 2020 |
Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Carcinoma; Female; Fibrinogen; Fibronectins; Humans; Immunohistochemistry; Integrin alphaVbeta3; Integrins; Male; Melanoma; Prognosis; Receptors, Vitronectin; Skin Neoplasms | 2013 |
Imaging of thrombosis and microcirculation in mouse lungs of initial melanoma metastasis with in vivo cryotechnique.
Topics: Animals; Blood Coagulation; Blood Platelets; Cell Line, Tumor; Fibrinogen; Freezing; Glutathione; Lung; Lung Neoplasms; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microcirculation; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activation; Platelet Aggregation; Quantum Dots; src-Family Kinases; Thrombosis | 2014 |
PDMS substrate stiffness affects the morphology and growth profiles of cancerous prostate and melanoma cells.
Topics: Biomechanical Phenomena; Cell Line, Tumor; Cell Proliferation; Dimethylpolysiloxanes; Elasticity; Fibrinogen; Humans; Male; Mechanical Phenomena; Melanoma; Microchip Analytical Procedures; Prostatic Neoplasms; Surface Properties | 2015 |
Sequential binding of αVβ3 and ICAM-1 determines fibrin-mediated melanoma capture and stable adhesion to CD11b/CD18 on neutrophils.
Topics: Animals; Blood Flow Velocity; CD11b Antigen; CD18 Antigens; Cell Adhesion; Cell Communication; Cell Line, Tumor; Fibrin; Fibrinogen; Humans; Inflammation Mediators; Integrin alphaVbeta3; Intercellular Adhesion Molecule-1; Melanoma; Mice; Neutrophil Infiltration; Thrombosis | 2011 |
Endogenous activated protein C is essential for immune-mediated cancer cell elimination from the circulation.
Topics: Animals; Antigens, CD; Blood Coagulation; Blood Platelets; Cadherins; Fibrinogen; Immune System; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasm Metastasis; Protein C; Receptors, Lysosphingolipid; Thrombin | 2011 |
Pretherapeutic laboratory findings, extent of metastasis and choice of treatment as prognostic markers in ocular melanoma- a single centre experience.
Topics: Albumins; Biomarkers; C-Reactive Protein; Disease-Free Survival; Female; Fibrinogen; Humans; L-Lactate Dehydrogenase; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Uveal Neoplasms | 2013 |
Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels.
Topics: Albumins; Animals; Antigens, Neoplasm; Bacteriophage T7; Drug Carriers; Drug Delivery Systems; Fibrinogen; Glioma; Integrins; Iodine Radioisotopes; Liposomes; Melanoma; Mice; Nanotechnology; Neoplasm Transplantation; Neoplasms; Peptides; Radioimmunotherapy; Regional Blood Flow; Tumor Cells, Cultured; Ultrasonography, Doppler | 2003 |
[Demonstration].
Topics: Afibrinogenemia; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Medical Records; Melanoma; Vaginal Neoplasms | 1957 |
[I-131 LABELED FIBRINOGEN IN THE DIAGNOSIS OF CUTANEOUS NEOPLASMS. PREVENTIVE NOTE].
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fibrinogen; Genetic Diseases, X-Linked; Hemangioma; Histiocytoma, Benign Fibrous; Humans; Iodine Isotopes; Leukemia, Hairy Cell; Lymphatic Diseases; Melanoma; Neoplasms; Radiometry; Severe Combined Immunodeficiency; Skin Neoplasms; Skin Ulcer | 1964 |
Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis.
Topics: Animals; Blood Platelets; Cell Line, Tumor; Disease Models, Animal; Female; Fibrinogen; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Neoplasm Transplantation; Neoplastic Cells, Circulating; Receptor, PAR-1; Receptor, PAR-2; Receptors, Thrombin; Skin Neoplasms | 2004 |
Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation.
Topics: Adenocarcinoma; Animals; Blood Coagulation; Blood Platelets; Cell Communication; Cell Line, Tumor; Colonic Neoplasms; Fibrinogen; Fibrosarcoma; Hirudins; Humans; Lung; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasms; Neoplastic Cells, Circulating; Rats; Thrombin | 2004 |
Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques.
Topics: Adult; Aged; Alpha-Globulins; Amino Acid Sequence; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Fibrinogen; Gene Expression Profiling; Humans; Lasers; Male; Mass Spectrometry; Melanoma; Neoplasm Proteins; Peptides; Proteomics; Skin Neoplasms | 2005 |
Effects of human plasma proteins on maturation of monocyte-derived dendritic cells.
Topics: Antigens, CD; Blood Proteins; CD83 Antigen; Cell Differentiation; Cells, Cultured; Dendritic Cells; Dose-Response Relationship, Drug; Fibrinogen; Humans; Immunoglobulins; Immunophenotyping; Lymphocyte Culture Test, Mixed; Melanoma; Membrane Glycoproteins; Monocytes | 2005 |
131-I-labeled antibodies to human fibrinogen. Diagnostic studies and therapeutic trials.
Topics: Antibodies; Antifibrinolytic Agents; Brain Neoplasms; Breast Neoplasms; Carcinoma; Fibrinogen; Fibrinolytic Agents; Humans; Iodine Isotopes; Iodine Radioisotopes; Melanoma; Neoplasms; Radionuclide Imaging; Sarcoma | 1967 |
Interaction of human tumor cells with human platelets and the coagulation system.
Topics: Adenocarcinoma; Blood Platelets; Breast Neoplasms; Cell Line; Cells, Cultured; Factor VII; Factor X; Fibrin; Fibrinogen; Hemostasis; Humans; In Vitro Techniques; Iodine Radioisotopes; Melanoma | 1983 |
Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Topics: alpha-2-Antiplasmin; Endopeptidases; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; In Vitro Techniques; Iodine Radioisotopes; Isotope Labeling; Melanoma; Plasminogen; Plasminogen Activators; Urokinase-Type Plasminogen Activator | 1981 |
Deep venous thromboembolism in patients undergoing inguinal lymph node dissection for melanoma.
Topics: Bed Rest; Double-Blind Method; Female; Fibrinogen; Heparin; Humans; Iodine Radioisotopes; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Staging; Pulmonary Embolism; Risk; Thrombophlebitis | 1981 |
Cell surface proteolysis by serine proteinases enhances RGD-sensitive melanoma cell adhesion on fibrinogen and vitronectin.
Topics: Amino Acid Sequence; Cell Adhesion; Chymotrypsin; Extracellular Matrix Proteins; Fibrinogen; Fibrinolysin; Glycoproteins; Humans; Integrins; Laminin; Melanoma; Molecular Sequence Data; Oligopeptides; Receptors, Cytoadhesin; Receptors, Vitronectin; Serine Endopeptidases; Trypsin; Tumor Cells, Cultured; Up-Regulation; Vitronectin | 1995 |
Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3.
Topics: Animals; Antibodies; Antigens, CD; Cell Line; CHO Cells; Clot Retraction; Cricetinae; Endothelium, Vascular; Fibrin; Fibrinogen; Gene Expression; Humans; Immunosorbent Techniques; Integrin beta3; Integrins; Melanoma; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Cytoadhesin; Receptors, Vitronectin; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1995 |
Modification of integrin-mediated cell attachment to substrata by serine proteinases in the presence and absence of divalent cations.
Topics: Amino Acid Sequence; Calcium; Cations, Divalent; Cell Adhesion; Chymotrypsin; Extracellular Matrix; Fibrinogen; Fibronectins; Glycoproteins; Humans; In Vitro Techniques; Integrins; Laminin; Melanoma; Molecular Sequence Data; Molecular Weight; Oligopeptides; Tumor Cells, Cultured; Vitronectin | 1993 |
The activation of type 1 and type 2 plasminogen by type I and type II tissue plasminogen activator.
Topics: Amino Acid Sequence; Chromatography, Affinity; Cysteine; Disulfides; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Fibrinogen; Glycosylation; Humans; Isoenzymes; Kinetics; Macromolecular Substances; Melanoma; Models, Molecular; Molecular Weight; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Protein Structure, Secondary; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1995 |
Ussuristatin 2, a novel KGD-bearing disintegrin from Agkistrodon ussuriensis venom.
Topics: Agkistrodon; Amino Acid Sequence; Animals; Cell Adhesion; Crotalid Venoms; Dimerization; Disintegrins; Fibrinogen; Fibronectins; Humans; Melanoma; Molecular Sequence Data; Platelet Aggregation; Platelet Aggregation Inhibitors; Sequence Homology, Amino Acid; Tumor Cells, Cultured; Viper Venoms | 1999 |
Beta1 integrin antisense oligodeoxynucleotides: utility in controlling osteoclast function.
Topics: Animals; Base Sequence; Blood Proteins; Bone Marrow Cells; Bone Resorption; Calcitonin; Cell Adhesion; Cells, Cultured; Collagen; Dentin; Dimerization; Down-Regulation; Extracellular Matrix Proteins; Fibrinogen; Fibronectins; Gene Expression Regulation; Glass; Humans; Integrin beta1; Integrins; Melanoma; Molecular Sequence Data; Oligonucleotides, Antisense; Osteoclasts; Rabbits; Receptors, Collagen; Receptors, Vitronectin; Sequence Alignment; Sequence Homology, Nucleic Acid; Tumor Cells, Cultured; Vitronectin | 1999 |
A cell-based adhesion assay for the characterization of integrin alpha v beta 3 antagonists.
Topics: Amino Acid Sequence; Antibodies; Cell Adhesion; Cell Culture Techniques; Fibrinogen; Humans; Indicators and Reagents; Melanoma; Oligopeptides; Receptors, Vitronectin; Tumor Cells, Cultured | 1999 |
A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Fibrinogen; Fibronectins; Humans; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; Osteosarcoma; Peptide Fragments; Receptors, Vitronectin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2001 |
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.
Topics: Animals; Azides; Biomarkers, Tumor; DNA-Binding Proteins; Female; Fibrinogen; Fluorine Radioisotopes; Galactose; Humans; Isotope Labeling; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Osteosarcoma; Peptides, Cyclic; Radiopharmaceuticals; Receptors, Vitronectin; Tissue Distribution; Tomography, Emission-Computed; Transcription Factors; Transplantation, Heterologous; Vitronectin | 2001 |
Ectopic alphaIIbbeta3 integrin signaling involves 12-lipoxygenase- and PKC-mediated serine phosphorylation events in melanoma cells.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Antibodies, Monoclonal; Arachidonate 12-Lipoxygenase; Cell Adhesion; Enzyme Inhibitors; Fibrinogen; Flow Cytometry; Melanoma; Mice; Microscopy, Confocal; Phosphorylation; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Kinase C; Serine; Signal Transduction; Tumor Cells, Cultured | 2001 |
Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions.
Topics: Actins; Antineoplastic Agents; Calcium; Cell Adhesion; Cell Membrane; Cross-Linking Reagents; Dose-Response Relationship, Drug; Fibrinogen; Humans; Ligands; Melanoma; Microscopy, Fluorescence; Protein Binding; Receptors, Vitronectin; Time Factors; Tumor Cells, Cultured | 2002 |
Plasma viscosity in 615 subjects. Effect of fibrinogen, globulin, and cholesterol in normals, peripheral vascular disease retinopathy, and melanoma.
Topics: Blood Viscosity; Cholesterol; Fibrinogen; Humans; Male; Melanoma; Retinal Diseases; Serum Globulins; Vascular Diseases | 1977 |
Some aspects of haemorrheology of metastasis in malignant melanoma.
Topics: ABO Blood-Group System; Adult; Blood Coagulation; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Hematocrit; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Rheology; Serum Globulins | 1977 |
[Blood coagulation and fibrinolysis system in malignant melanoma of the skin].
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Female; Fibrinogen; Fibrinolysis; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Remission, Spontaneous; Skin Neoplasms | 1978 |
Elevation of plasma viscosity and of aggregation of red cells in melanoma metastasis.
Topics: Adult; Blood Viscosity; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Male; Melanoma; Neoplasm Metastasis; Serum Albumin; Serum Globulins; Sex Factors; Time Factors | 1978 |
Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: roles of heparin, plasma adhesive proteins, and tumor cell membrane proteins.
Topics: Antibodies, Monoclonal; Azepines; Blood Coagulation Factors; Calcium; Cells, Cultured; Citrates; Citric Acid; Fibrinogen; Flow Cytometry; Heparin; In Vitro Techniques; Magnesium; Melanoma; Membrane Proteins; Microbial Collagenase; Neuraminidase; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Thrombospondins; Triazoles; Trypsin | 1991 |
Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator.
Topics: Amino Acid Sequence; Fibrin; Fibrinogen; Fibrinolysin; Humans; Kinetics; Melanoma; Molecular Sequence Data; Oligopeptides; Peptide Fragments; Substrate Specificity; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1990 |
Evaluation of epithelial tissue plasminogen activator as a thrombolytic agent in a rabbit model of venous thrombosis.
Topics: alpha-2-Antiplasmin; Animals; Disease Models, Animal; Epithelium; Fibrinogen; Fibrinolysis; Fibroblasts; Humans; Keratins; Melanoma; Partial Thromboplastin Time; Phlebitis; Plasminogen Activators; Rabbits; Rats | 1986 |
Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor.
Topics: Cell Adhesion; Cell Line; Chromatography, Affinity; Fibrinogen; Flow Cytometry; Fluorescent Antibody Technique; Glycoproteins; Humans; Melanoma; Oligopeptides; Receptors, Immunologic; Receptors, Peptide; Tumor Cells, Cultured; Vitronectin; von Willebrand Factor | 1987 |
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells.
Topics: Adenocarcinoma; Amino Acid Sequence; Blotting, Northern; Cell Adhesion; Cell Line; Electrophoresis, Gel, Two-Dimensional; Fibrinogen; Fibroblasts; Fibronectins; Glycoproteins; Humans; Integrins; Lung Neoplasms; Melanoma; Membrane Glycoproteins; Receptors, Immunologic; Receptors, Vitronectin; RNA, Messenger; Vitronectin; von Willebrand Factor | 1989 |
Lectin affinity bioassay: an assay method for glycoprotein enzyme.
Topics: Alkaline Phosphatase; Biological Assay; Concanavalin A; Fibrinogen; Glycoproteins; Lectins; Melanoma; Plasminogen; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1989 |
Trigramin, an RGD-containing peptide from snake venom, inhibits cell-substratum adhesion of human melanoma cells.
Topics: Cell Adhesion; Cells, Cultured; Fibrinogen; Fibronectins; Humans; Integrins; Intercellular Signaling Peptides and Proteins; Melanoma; Membrane Glycoproteins; Microscopy, Phase-Contrast; Oligopeptides; Peptides; Snake Venoms | 1988 |
[The inhibitory effect of batroxobin against the lung metastasis of the B16-F10 melanoma cells implanted in the mice in relation to the activity of the NK cell].
Topics: Animals; Batroxobin; Cytotoxicity, Immunologic; Fibrinogen; Killer Cells, Natural; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Serine Endopeptidases | 1988 |
Antitumor action of crotalase, a defibrinogenating snake venom enzyme.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Endopeptidases; Fibrinogen; Isoflurophate; Melanoma; Mice; Mice, Inbred C57BL; Mitosis; Serine Endopeptidases | 1986 |
Discriminating neoantigenic differences between fibrinogen and fibrin derivatives.
Topics: Abruptio Placentae; Acute Kidney Injury; Adenocarcinoma; Binding Sites, Antibody; Binding, Competitive; Blood Coagulation Disorders; Epitopes; Female; Fibrin; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Immune Sera; Iodine Isotopes; Male; Melanoma; Meningococcal Infections; Peritonitis; Pregnancy; Prostatic Neoplasms; Radioimmunoassay; Structure-Activity Relationship | 1973 |
Influence of ABO blood groups and fibrinogen on thrombus formation and aggregation of red cells in cardiovascular and malignant diseases: new aspects of biorheological characterization of disease.
Topics: ABO Blood-Group System; Blood Coagulation; Blood Sedimentation; Blood Viscosity; Cardiovascular Diseases; Cell Aggregation; Diabetes Mellitus; Erythrocytes; Fibrinogen; Graft Rejection; Hematocrit; Hemophilia A; Humans; Hyperthyroidism; Kidney Failure, Chronic; Kidney Transplantation; Melanoma; Myocardial Infarction; Prognosis; Rheology; Serum Albumin; Thrombosis; Transplantation, Homologous | 1973 |
Blood viscosity factors and prognosis in malignant melanoma. Effect of abo blood groups.
Topics: ABO Blood-Group System; Adult; Aged; Blood Sedimentation; Blood Viscosity; Female; Fibrinogen; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Prognosis; Serum Albumin | 1973 |
Hypofibrinogenemia due to L-asparaginase: studies of fibrinogen survival using autologous 131-I-fibrinogen.
Topics: Adenocarcinoma; Adult; Afibrinogenemia; Asparaginase; Breast Neoplasms; Female; Fibrinogen; Humans; Iodine Radioisotopes; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Male; Melanoma; Middle Aged; Neuroblastoma | 1970 |
Clinical experience with L-asparaginase.
Topics: Asparaginase; Bone Marrow Cells; Child; Drug Hypersensitivity; Erwinia; Escherichia coli; Female; Fibrinogen; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Liver Function Tests; Lymphoma, Non-Hodgkin; Melanoma; Nausea; Serum Albumin; Species Specificity; Vomiting | 1970 |
Some clinical observations on the treatment with L-asparaginase of the acute leukemias.
Topics: Acute Disease; Adolescent; Adult; Aged; Asparaginase; Blood Chemical Analysis; Blood Platelets; Body Temperature; Bone Marrow Examination; Chemical and Drug Induced Liver Injury; Child; Erythrocyte Count; Escherichia coli; Fibrinogen; Hemoglobins; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma, Non-Hodgkin; Male; Melanoma; Uric Acid | 1970 |
Defibrination and metastasis formation: effects of arvin on experimental metastases in mice.
Topics: Animals; Anticoagulants; Blood Coagulation; Fibrinogen; Melanoma; Mice; Neoplasm Metastasis; Neoplasms, Experimental; Sarcoma, Experimental; Time Factors; Venoms | 1972 |
[On blood coagulation disorders during enzyme therapy of malignant tumors and hemoblastoses].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Asparaginase; Blood Coagulation Disorders; Blood Platelets; Bone Neoplasms; Child; Choroid Neoplasms; Factor V; Factor VIII; Female; Fibrinogen; Fibrinolysis; Humans; Leukemia, Lymphoid; Male; Melanoma; Neoplasm Metastasis; Plasmacytoma; Thrombelastography | 1969 |
Platelet cold agglutinins.
Topics: Adult; Aged; Animals; Antibodies; Antigen-Antibody Reactions; Blood Platelets; Carcinoma, Squamous Cell; Cold Temperature; Felty Syndrome; Female; Fibrinogen; Hemagglutination Tests; Hepatitis B; Humans; Hypersplenism; Immunochemistry; Immunoglobulins; Male; Melanoma; Middle Aged; Molecular Weight; Neoplasm Metastasis; Rabbits; Thrombocytopenia | 1970 |
Changes in coagulation factors after hepatic dearterialization in man.
Topics: Aged; Blood Coagulation Factors; Eye Neoplasms; Factor VII; Factor X; Female; Fibrinogen; Hepatic Artery; Humans; Leiomyosarcoma; Liver; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Peritoneal Neoplasms; Prothrombin; Sigmoid Neoplasms | 1968 |
[The localization of the tissue activator of fibrinolysis in skin tumors].
Topics: Connective Tissue; Ectoderm; Fibrinogen; Fibrinolysis; Hemangioma; Humans; Melanoma; Skin Neoplasms; Thrombin; Thrombosis | 1969 |